Skip to main content
Retour
Watch Compare

Zura Bio Ltd

Qualité des données : 83%
ZURA
Nasdaq Manufacturing Chemicals
5,62 €
▼ 0,08 € (-1,39%)
Cap. Boursière: 533,32 M
Prix
5,62 €
Cap. Boursière
533,32 M
Fourchette du Jour
5,55 € — 5,81 €
Fourchette 52 Semaines
0,98 € — 7,44 €
Volume
407 352
Ouverture 5,67 €
Moyenne 50J / 200J
6,26 €
10,15% below
Moyenne 50J / 200J
3,82 €
47,19% above

Quick Summary

Points Clés

Negative free cash flow of -64,93 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-58,64%
En dessous de la moyenne du secteur (-53,47%)
ROIC-46,16%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio5,58
Interest CoverageN/A

Valorisation

PE (TTM)
-7,77
En dessous de la moyenne du secteur (-1,47)
P/B Ratio4,93
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -7,8 -1,5
P/B 4,9 1,6
ROE % -58,6 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

BRUSX BRUSX
0,68% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -68,65 M
ROE -58,64% ROA -45,50%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -64,93 M
ROIC -46,16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5,58
Interest Coverage N/A Asset Turnover N/A
Working Capital 116,80 M Tangible Book Value 108,24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7,77 Forward P/E N/A
P/B Ratio 4,93 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -12,17%
Market Cap 533,32 M Enterprise Value 394,31 M
Per Share
EPS (Diluted TTM) -1,06 Revenue / Share N/A
FCF / Share -0,68 OCF / Share -0,68
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 94,58%
SBC-Adj. FCF -83,33 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue — — — — —
Net Income -68,65 M -52,40 M -60,36 M 6,85 M 3,55 M
EPS (Diluted) -1,06 -0,60 -2,09 — —
Gross Profit — — — — —
Operating Income -75,25 M -55,19 M -62,64 M -888 545,0 -2,68 M
EBITDA — — — — —
R&D Expenses 42,08 M 24,40 M 44,00 M — —
SG&A Expenses — — — — —
D&A 49 000,0 9 000,0 — — —
Interest Expense — — — — —
Income Tax — 0,0 0,0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 113,95 M 179,53 M 100,84 M 140,55 M 141,51 M
Total Liabilities 12,41 M 19,51 M 21,29 M 10,35 M 7,76 M
Shareholders' Equity 101,54 M 146,82 M 59,33 M -9,18 M -7,63 M
Total Debt — — — — —
Cash & Equivalents 109,41 M 176,50 M 99,80 M 729 223,0 13 785,0
Current Assets 112,31 M 178,74 M 100,84 M 1,15 M 33 487,0
Current Liabilities 12,41 M 19,51 M 20,30 M 272 292,0 1,83 M